1. Functions of mesolimbic dopamine: changing concepts and shifting paradigms

   • John D. Salamone

   Editorial 10 November 2006 Pages: 389 - 389

2. The debate over dopamine’s role in reward: the case for incentive salience

   • Kent C. Berridge

   Review 27 October 2006 Pages: 391 - 431

   

3. A role for mesencephalic dopamine in activation: commentary on Berridge (2006)

   • T. W. Robbins
   • B. J. Everitt

   Review 15 September 2006 Pages: 433 - 437

4. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding

   • Brian A. Baldo
   • Ann E. Kelley

   Review 23 February 2007 Pages: 439 - 459

   

5. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits

   • J. D. Salamone
   • M. Correa
   • S. M. Mingote

   Review 16 January 2007 Pages: 461 - 482

   

6. Calculating utility: preclinical evidence for cost–benefit analysis by mesolimbic dopamine

   • Paul E. M. Phillips
   • Mark E. Walton
   • Thomas C. Jhou

   Review 22 November 2006 Pages: 483 - 495

   

7. Opioids for hedonic experience and dopamine to get ready for it

   • M. Flavia Barbano
   • Martine Cador

   Review 10 October 2006 Pages: 497 - 506

   

8. Tonic dopamine: opportunity costs and the control of response vigor

   • Yael Niv
   • Nathaniel D. Daw
   • Peter Dayan

   Original Investigation 10 October 2006 Pages: 507 - 520

   

9. The nucleus accumbens as part of a basal ganglia action selection circuit

   • Saleem M. Nicola

   Review 16 September 2006 Pages: 521 - 550

   

10. Intact discrimination reversal learning but slowed responding to reward-predictive cues after dopamine D1 and D2 receptor blockade in the nucleus accumbens of rats

    • Carsten Calaminus
    • Wolfgang Hauber

    Original Investigation 05 October 2006 Pages: 551 - 566

    

11. Viral restoration of dopamine signaling to the dorsal striatum restores instrumental conditioning to dopamine-deficient mice

    • Siobhan Robinson
    • Aundrea J. Rainwater
    • Richard D. Palmiter

    Original Investigation 09 November 2006 Pages: 567 - 578

    

12. Adenosine A_2A receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing

    • Andrew M. Farrar
    • Mariana Pereira
    • John D. Salamone

    Original Investigation 27 October 2006 Pages: 579 - 586

    

13. Involvement of dopamine D₁ and D₂ receptors in the nucleus accumbens core and shell in inhibitory response control

    • Tommy Pattij
    • Mieke C. W. Janssen
    • Marcel M. van Gaalen

    Original Investigation 14 September 2006 Pages: 587 - 598

    

14. Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats

    • Shelly B. Flagel
    • Stanley J. Watson
    • Huda Akil

    Original Investigation 14 September 2006 Pages: 599 - 607

    

15. The ability of the mesocortical dopamine system to operate in distinct temporal modes

    • Christopher C. Lapish
    • Sven Kroener
    • Jeremy K. Seamans

    Review 04 November 2006 Pages: 609 - 625

    

16. Dopaminergic modulation of striatal plateau depolarizations in corticostriatal organotypic cocultures

    • Kuei Y. Tseng
    • Abigail Snyder-Keller
    • Patricio O’Donnell

    Original Investigation 07 June 2006 Pages: 627 - 640

    

17. Dopamine efflux in the nucleus accumbens during within-session extinction, outcome-dependent, and habit-based instrumental responding for food reward

    • Soyon Ahn
    • Anthony G. Phillips

    Original Investigation Open access 08 September 2006 Pages: 641 - 651

    

18. Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat

    • Daniele Lecca
    • Fabio Cacciapaglia
    • Gaetano Di Chiara

    Original Investigation 24 August 2006 Pages: 653 - 667

    

19. Adderall^® produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers

    • B. Matthew Joyce
    • Paul E. A. Glaser
    • Greg A. Gerhardt

    Original Investigation 10 October 2006 Pages: 669 - 677

    

20. Increased accumbal dopamine during daily alcohol consumption and subsequent aggressive behavior in rats

    • Annemoon M. M. van Erp
    • Klaus A. Miczek

    Original Investigation 29 November 2006 Pages: 679 - 688

    

21. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex

    • Valentina Bassareo
    • Maria Antonietta De Luca
    • Gaetano Di Chiara

    Original Investigation 28 October 2006 Pages: 689 - 703

    

22. Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction

    • Charles W. Bradberry

    Review 10 October 2006 Pages: 705 - 717

    

23. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats

    • Danielle L. Graham
    • Regis Hoppenot
    • David W. Self

    Original Investigation 12 July 2006 Pages: 719 - 730

    

24. Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice

    • Rebecca J. Ralph
    • S. Barak Caine

    Original Investigation 22 September 2006 Pages: 731 - 739

    

25. Unique pharmacological profile of aripiprazole as the phasic component buster

    • Takashi Hamamura
    • Toshiki Harada

    Letter to the Editors 05 January 2007 Pages: 741 - 743

    

26. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain

    • A. Bortolozzi
    • L. Díaz-Mataix
    • F. Artigas

    Original Investigation 30 January 2007 Pages: 745 - 758

    

27. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats

    • Kerstin Schwabe
    • Michael Koch

    Original Investigation 05 September 2006 Pages: 759 - 765

    

28. Discriminative stimulus properties of S32504, a novel D₃/D₂ receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D₂ but not D₃ receptors

    • Mark J. Millan
    • Loretta Iob
    • Anne Dekeyne

    Original Investigation 19 September 2006 Pages: 767 - 782

    

29. Neonatal exposure to epidermal growth factor induces dopamine D₂-like receptor supersensitivity in adult sensorimotor gating

    • Hidekazu Sotoyama
    • Hisaaki Namba
    • Hiroyuki Nawa

    Original Investigation 10 November 2006 Pages: 783 - 792

    

30. Dopamine D₂ receptor-dependent modulation of striatal NO synthase activity

    • Stephen Sammut
    • Kristina E. Bray
    • Anthony R. West

    Original Investigation 06 January 2007 Pages: 793 - 803

    

31. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait

    • Jose J. Mateos
    • Francisco Lomeña
    • Miquel Bernardo

    Original Investigation 22 September 2006 Pages: 805 - 811

    

32. Linking nucleus accumbens dopamine and blood oxygenation

    • Brian Knutson
    • Sasha E. B. Gibbs

    Review 06 February 2007 Pages: 813 - 822

    

33. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study

    • Birgit Abler
    • Susanne Erk
    • Henrik Walter

    Original Investigation 31 January 2007 Pages: 823 - 833

    

34. Medial prefrontal cortical alpha₁ adrenoreceptor modulation of the nucleus accumbens dopamine response to stress in Long–Evans rats

    • Brid NicNiocaill
    • Alain Gratton

    Original Investigation 09 February 2007 Pages: 835 - 842

    

35. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo

    • Giuliano Pillolla
    • Miriam Melis
    • Marco Pistis

    Original Investigation 16 February 2007 Pages: 843 - 853

    

36. Unique pharmacological profile of aripiprazole as the phasic component buster

    • Takashi Hamamura
    • Toshiki Harada

    Erratum 09 February 2007 Pages: 855 - 855